117
Views
4
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes Original Research

Angiopoietin-2 level as a tool for cardiovascular risk stratification in hypertensive type 2 diabetic subjects

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 402-408 | Received 07 Dec 2017, Accepted 23 Apr 2018, Published online: 08 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jay Bilimoria & Harprit Singh. (2019) The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease. Journal of Receptors and Signal Transduction 39:3, pages 187-193.
Read now

Articles from other publishers (3)

Hamzah Osop, Hai-Yan Xu & Xiuju Fu. (2022) A Review of Approaches in the Development of Risk Stratification Models for Diabetic Patients at Risk of Vascular Complications. IFAC-PapersOnLine 55:10, pages 1631-1638.
Crossref
Lei Tang, Ping Li & Ling Li. (2020) Whole transcriptome expression profiles in placenta samples from women with gestational diabetes mellitus. Journal of Diabetes Investigation 11:5, pages 1307-1317.
Crossref
Zenghao Yan, Hao Wu, Hongliang Yao, Wenjun Pan, Minmin Su, Taobin Chen, Weiwei Su & Yonggang Wang. (2019) Rotundic Acid Protects against Metabolic Disturbance and Improves Gut Microbiota in Type 2 Diabetes Rats. Nutrients 12:1, pages 67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.